Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Indian Health Service Nirsevimab Vaccine Update
2024
· Indian Health Service
This document provides information on nirsevimab and recommendations for its use, including an administration visual guide. It addresses the documentation of administered doses and reconciliation …
Ask aRCie
Nirsevimab Administration Visual Guide
This 2-page infographic includes a flowchart to aid in making decisions about nirsivemab administration and dosing in infants and toddlers. It provides immunization administration tips, …
Nirsevimab
This webpage features the drug dictionary entry for nirsevimab, providing the National Cancer Institute's definition. It describes nirsevimab as a special type of medicine called …
Beyfortus-nirsevimab injection (Drug Label Information)
2024
· National Library of Medicine
This webpage provides drug label information for the Beyfortus- nirsevimab injection. It describes the drug's dosage, forms, and strengths. Beyfortus is given as an injection …
Nirsevimab (Beyfortus) Product & Ordering Information
This webpage provides information about nirsevimab (Beyfortus), describing the different doses available, how to order and store it, and its cost. Practices need to forecast …
Nirsevimab Frequently Asked Questions
This webpage provides answers to frequently asked questions (FAQs) about nirsevimab, a monoclonal antibody used to prevent RSV in infants and young children. Topics include …
Interim Immunization Protocol (RSV)
2025
· Oregon Health Authority
The Interim Immunization Protocol for RSV vaccines Abrysvo, Arexvy, and mResvia outlines guidelines for use. It describes the vaccine schedule, who should get vaccinated (pregnant …
Respiratory Viruses Vaccine Recommendations
This site provides vaccine recommendations for respiratory viruses like COVID-19, flu, and RSV. It describes who should get vaccinated and when. Everyone 6 months and …
Nirsevimab Clinical Guidance and VFC Ordering [Letter]
This letter provides clinical guidance on the use of nirsevimab (Beyfortus), a monoclonal antibody that protects infants and toddlers from respiratory syncytial virus (RSV). Information …
Nirsevimab for RSV Prevention in Late Preterm and Term Infants | NEJM
2022
· NEJM Group
This short video summarizes new research findings on nirsevimab and how it can prevent RSV in late preterm and term infants. The trial included 1490 …